$28.37
0.150.53%
Last update: Oct 26, 4:00 PM
Zymeworks Inc (ZYME) Stock Price, Quote, News & History
ZYMENASDAQ
Zymeworks completes its Theravance Biopharma acquisition, boosts 2026 revenue guidance, and gains recurring revenue from YUPELRI sales.
You can purchase shares of Zymeworks (NASDAQ:ZYME) through any online brokerage.
Other companies in Zymeworks’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Zymeworks has a consensus price target of $39.54.
The stock price for Zymeworks (NASDAQ: ZYME) is $28.23 last updated October 26, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Zymeworks.
Zymeworks does not have any upcoming earnings scheduled.
There is no upcoming split for Zymeworks.
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development...
